Stocks Hitting 52-Week Lows

shares reached a new 52-week low of $3.41. Argos Therapeutics reported a Q3 loss of $0.97 per share on revenue of $158,000.

shares fell 4.76 percent to touch a new 52-week low of $27.69. Deutsche Bank downgraded Five Below from Buy to Hold and lowered the price target to $30.

shares reached a new 52-week low of $18.56. Stifel Nicolaus downgraded Sabra Health Care REIT from Buy to Hold.

shares touched a new 52-week low of $68.06 after the company reported weaker-than-expected Q3 earnings.